About this trial
Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.
For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.
Eligibility criteria
Qualifiers
Female patients aged 25-50 years
Literate and able to comprehend written and spoken instructions
Diagnosed with relapsing-remitting form of multiple sclerosis
Having a continuous/regular sexual partner
Disqualifiers
Pregnancy
Illiteracy or inability to understand spoken or written instructions
Absence of a continuous/regular sexual partner
Expanded Disability Status Scale (EDSS) score > 5
Trial design
Treatments tested in this trial
- Not listed